Actively Recruiting
Molecular Analysis of Oncogenes and Resistance Mechanisms in Lung Cancer
Led by University of Colorado, Denver · Updated on 2026-02-18
500
Participants Needed
1
Research Sites
888 weeks
Total Duration
On this page
Sponsors
U
University of Colorado, Denver
Lead Sponsor
N
National Cancer Institute (NCI)
Collaborating Sponsor
AI-Summary
What this Trial Is About
The mechanisms of sensitivity and resistance to oncogene-targeted therapy can be determined from tumor tissue or tumor cell lines derived from available archival samples and/or from standard-of-care re-biopsy upon suspected tumor progression.
CONDITIONS
Official Title
Molecular Analysis of Oncogenes and Resistance Mechanisms in Lung Cancer
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients undergoing investigation or treatment for thoracic cancers with oncogene-targeted therapies
- Aged 18 years or older
- Have suspected tumor progression or another condition requiring a standard-of-care intervention (such as biopsy or surgery) providing tumor tissue for molecular analysis, or have previously had tumor tissue collected available for analysis
- Ability to understand and willingness to sign an informed consent document
You will not qualify if you...
null
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University of Colorado Cancer Center
Aurora, Colorado, United States, 80045
Actively Recruiting
Research Team
B
Brandi Kubala
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here